• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类二十烷酸及相关化合物的降眼压疗效比较。

Comparison of the ocular hypotensive efficacy of eicosanoids and related compounds.

作者信息

Bito L Z

出版信息

Exp Eye Res. 1984 Feb;38(2):181-94. doi: 10.1016/0014-4835(84)90102-7.

DOI:10.1016/0014-4835(84)90102-7
PMID:6370708
Abstract

It has recently been shown that prostaglandin (PG)E2 or F2 alpha reduces the intraocular pressure (IOP) of cats and primates when applied topically to the eye in very small doses, and that reduced IOP can be maintained in these species as long as the topical application of one of these PGs is repeated daily or twice daily. In the present study the ocular hypotensive efficacy and some of the ocular side-effects of 15 eicosanoids and related compounds, especially derivatives of PGF2 alpha, were compared and were also compared to some clinically used ocular hypotensive agents. Derivatives of PGF2 alpha were found that had short-term and long-term ocular hypotensive potencies some 10- to 50-fold greater than PGF2 alpha itself.

摘要

最近有研究表明,前列腺素(PG)E2或F2α以非常小的剂量局部应用于眼部时,可降低猫和灵长类动物的眼压(IOP),并且只要每天或每天两次重复局部应用这些PG中的一种,这些物种的眼压降低就能得以维持。在本研究中,比较了15种类二十烷酸及其相关化合物,特别是PGF2α衍生物的降眼压效果和一些眼部副作用,同时也与一些临床使用的降眼压药物进行了比较。发现PGF2α衍生物的短期和长期降眼压效力比PGF2α本身大约高10至50倍。

相似文献

1
Comparison of the ocular hypotensive efficacy of eicosanoids and related compounds.类二十烷酸及相关化合物的降眼压疗效比较。
Exp Eye Res. 1984 Feb;38(2):181-94. doi: 10.1016/0014-4835(84)90102-7.
2
Long-term maintenance of reduced intraocular pressure by daily or twice daily topical application of prostaglandins to cat or rhesus monkey eyes.通过每日或每日两次局部应用前列腺素于猫或恒河猴眼睛来长期维持降低的眼压。
Invest Ophthalmol Vis Sci. 1983 Mar;24(3):312-9.
3
Eicosanoids as a new class of ocular hypotensive agents. 2. Comparison of the apparent mechanism of the ocular hypotensive effects of A and F type prostaglandins.类二十烷酸作为一类新型的降眼压药物。2. A型和F型前列腺素降眼压作用的表观机制比较。
Invest Ophthalmol Vis Sci. 1987 Oct;28(10):1639-43.
4
Eicosanoids as a new class of ocular hypotensive agents. 3. Prostaglandin A2-1-isopropyl ester is the most potent reported hypotensive agent on feline eyes.类二十烷酸作为一类新型的降眼压药物。3. 前列腺素A2 - 1 - 异丙酯是已报道的对猫眼降压作用最强的药物。
Exp Eye Res. 1990 Apr;50(4):419-28. doi: 10.1016/0014-4835(90)90143-i.
5
Comparison of the hypotensive and other ocular effects of prostaglandins E2 and F2 alpha on cat and rhesus monkey eyes.前列腺素E2和F2α对猫和恒河猴眼睛的降压及其他眼部效应的比较。
Invest Ophthalmol Vis Sci. 1982 May;22(5):588-98.
6
Marked differential effects of prostanoid metabolites on rabbit intraocular pressure.前列腺素代谢产物对兔眼压的显著差异效应。
Ophthalmic Res. 1989;21(6):428-35. doi: 10.1159/000266933.
7
The effect of intravitreal and topical prostaglandins on intraocular inflammation.玻璃体内及局部应用前列腺素对眼内炎症的影响。
Invest Ophthalmol Vis Sci. 1982 Sep;23(3):383-92.
8
Studies on the characterisation of prostanoid receptors: a proposed classification.前列腺素受体特性的研究:一项拟议的分类法。
Prostaglandins. 1982 Nov;24(5):667-89. doi: 10.1016/0090-6980(82)90036-3.
9
Prostaglandin D2 reduces intraocular pressure.前列腺素D2可降低眼压。
Br J Ophthalmol. 1988 Jun;72(6):461-4. doi: 10.1136/bjo.72.6.461.
10
Eicosanoids as a new class of ocular hypotensive agents. 1. The apparent therapeutic advantages of derived prostaglandins of the A and B type as compared with primary prostaglandins of the E, F and D type.类花生酸作为一类新型的降眼压药物。1. A型和B型衍生前列腺素与E型、F型和D型初级前列腺素相比明显的治疗优势。
Exp Eye Res. 1987 Jun;44(6):825-37. doi: 10.1016/s0014-4835(87)80045-3.

引用本文的文献

1
Intraocular pressure reduction with once-a-day application of a new prostaglandin eye drop: a pilot placebo-controlled study in 12 patients.每日一次应用一种新前列腺素滴眼液降低眼内压:12 例患者的初步安慰剂对照研究。
Int Ophthalmol. 2020 Apr;40(4):823-831. doi: 10.1007/s10792-019-01243-0. Epub 2019 Dec 3.
2
Safety comparison of additives in antiglaucoma prostaglandin (PG) analog ophthalmic formulations.抗青光眼前列腺素(PG)类似物眼用制剂中添加剂的安全性比较
Clin Ophthalmol. 2013;7:515-20. doi: 10.2147/OPTH.S40147. Epub 2013 Mar 12.
3
The EP2 receptor is the predominant prostanoid receptor in the human ciliary muscle.
EP2受体是人类睫状肌中主要的前列腺素受体。
Br J Ophthalmol. 1993 Feb;77(2):110-4. doi: 10.1136/bjo.77.2.110.
4
Studies on a novel series of acyl ester prodrugs of prostaglandin F2 alpha.关于前列腺素F2α新型酰基酯前药系列的研究。
Br J Ophthalmol. 1994 Jul;78(7):560-7. doi: 10.1136/bjo.78.7.560.
5
Pharmacological advances in the treatment of glaucoma.青光眼治疗的药理学进展
Drugs Aging. 1994 Sep;5(3):156-70. doi: 10.2165/00002512-199405030-00002.
6
Synthesis, physicochemical properties, and cytotoxicity of a series of 5'-ester prodrugs of 5-iodo-2'-deoxyuridine.一系列5-碘-2'-脱氧尿苷的5'-酯前药的合成、理化性质及细胞毒性
Pharm Res. 1988 Nov;5(11):734-7. doi: 10.1023/a:1015968113838.
7
Prostaglandin F2 alpha-isopropylester eye drops: effects in normal human eyes.前列腺素F2α异丙酯滴眼液:对正常人类眼睛的影响。
Br J Ophthalmol. 1989 Jun;73(6):419-26. doi: 10.1136/bjo.73.6.419.
8
Prostaglandin F2 alpha-isopropylester eye drops: effect on intraocular pressure in open-angle glaucoma.前列腺素F2α异丙酯滴眼液:对开角型青光眼眼压的影响
Br J Ophthalmol. 1989 Dec;73(12):975-9. doi: 10.1136/bjo.73.12.975.
9
Ocular neovascularization. Experimental animal model and studies on angiogenic factor(s).眼部新生血管形成。实验动物模型及血管生成因子研究。
Int Ophthalmol. 1986 May;9(2-3):109-20. doi: 10.1007/BF00159839.
10
Prodrugs for the improvement of drug absorption via different routes of administration.用于通过不同给药途径改善药物吸收的前体药物。
Eur J Drug Metab Pharmacokinet. 1990 Apr-Jun;15(2):143-53. doi: 10.1007/BF03190197.